Immunome, Inc. (IMNM) Capital expenditures 2019–2025
Immunome, Inc. (IMNM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$9.7MFY2025 · since FY2019: $233,000 → $9.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.7M | +35.0% |
| FY2024 | $7.2M | +763.2% |
| FY2023 | $831,000 | +235.1% |
| FY2022 | $248,000 | +213.9% |
| FY2021 | $79,000 | -86.5% |
| FY2020 | $586,000 | +151.5% |
| FY2019 | $233,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice